RNA-Based Technologies and Pseudogenes: A Review of RN7SL87P (G106479255)

Target Name: RN7SL87P

NCBI ID: G106479255

RN7SL87P

Other Name(s): RNA, 7SL, cytoplasmic 87, pseudogene

RNA-Based Technologies and Pseudogenes: A Review of RN7SL87P

RNA-based technologies have revolutionized the field of genetics and have led to the discovery of numerous pseudogenes, which are functional RNA molecules that are similar to known genes but do not code for any functional proteins. One of these pseudogenes, RN7SL87P, has shown promise potential as a drug target and biomarker. In this article, we will explore the biology and potential applications of RN7SL87P.

Structure and Expression

RNA-based technologies have allowed researchers to identify and analyze the structure of RNA molecules. The structure of RNA molecules is crucial as it determines their function. The structure of RN7SL87P has been determined through various techniques such as RNA sequencing and biochemical assays.

RN7SL87P is a 21-kDa RNA molecule that consists of 87 amino acid residues. It is predominantly cytoplasmic and is located in the cytoplasm of the cell. The molecule has a specific structure that is similar to other known pseudogenes, such as HSP70 and HSP90.

Expression of RN7SL87P

RNA expression is a critical process in the development and progression of many diseases, including cancer. Researchers have been interested in studying the expression of RN7SL87P as a potential drug target or biomarker.

Studies have shown that RN7SL87P is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. The expression level of the molecule varies depending on the cell type and the experimental conditions used for its production.

Competitive Assay

Competitive assays are widely used to measure the levels of a specific protein or RNA molecule in a cell or tissue. One of the competitive assays used to study the expression of RN7SL87P is the RT-PCR (ribonucleic acid polymerase) assay.

This assay is used to measure the expression level of a specific gene or RNA molecule in a cell or tissue. The RT-PCR assay involves the use of a template that contains the specific RNA molecule of interest and amplification of the template using DNA polymerase . The amplified product can then be used to quantify the expression level of the RNA molecule.

In the context of RN7SL87P, researchers have used the RT-PCR assay to measure the expression level of the molecule in various tissues and cells. The results of these studies have shown that RN7SL87P is expressed in a variety of tissues and cells and that its expression level varies depending on the experimental conditions used for its production.

Drug Target Potential

RNA-based technologies have led to the identification of many pseudogenes, including RN7SL87P, that have the potential to serve as drug targets. A drug target is a protein or RNA molecule that is targeted by a drug to interact with and alter its function.

The potential drug targets for RN7SL87P are numerous and varied. One of the main targets of RN7SL87P is the cell signaling pathway known as the NF-kappa pathway. This pathway plays a role in the development and progression of many diseases, including cancer.

Research has shown that RN7SL87P can interact with the protein NF-kappa1 and that this interaction may play a role in the regulation of cell growth and differentiation. Additionally, studies have shown that RN7SL87P can interact with the protein p53, which is a well-known tumor suppressor protein that plays a critical role in the regulation of cell growth and apoptosis.

Another potential drug target for RN7SL87P is the protein NF-kappa-B, which is involved in the regulation of inflammation and immune responses.

Biomarker Potential

RN7SL87P has also been shown to have potential as a biomarker for several diseases, including cancer. The use of RNA-based technologies has allowed researchers to detect and measure the expression of specific genes or RNA molecules in various tissues

Protein Name: RNA, 7SL, Cytoplasmic 87, Pseudogene

The "RN7SL87P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SL87P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets